• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.07% Nasdaq Up 0.32%

    More On HIK.L

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Hikma Pharmaceuticals PLC (HIK.L)

    -LSE
    2,275.00 Down 2.00(0.09%) Aug 28, 11:35AM EDT
    Add to Portfolio
    Prev Close:2,277.00
    Open:2,281.00
    Bid:2,274.00
    Ask:2,276.00
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:2,250.00 - 2,284.00
    52wk Range:1,580.00 - 2,617.00
    Volume:402,699
    Avg Vol (3m):410,387
    Market Cap:4.53B
    P/E (ttm):18.72
    EPS (ttm):121.50
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in GBp.

    Headlines

    » More Headlines for HIK.L

    Key Statistics

    Forward P/E (1 yr):14.58
    P/S (ttm):310.36
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :1.35
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):1.67

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Hikma Pharmaceuticals PLC develops, manufactures, and markets a range of generic and in-licensed pharmaceutical products in solid, semi-solid, liquid, and injectable final dosage forms in the Middle East and North Africa, the United States, Europe... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback